AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ETODOLAC
10 registrations across 5 African markets— 7 active
Markets with ETODOLAC
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ETOVA-400 400MG COMPRIME PELLICULE BOITE DE 10 | 🇨🇮Côte d'Ivoire | IPCA LABORATORIES LIMITED | active | Mar 2028 |
| ETOVA-400 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | IPCA LABORATORIES LTD | active | Dec 2027 |
| SETOLAC ER 300MG COMPRIME BOITE DE 10 | 🇨🇮Côte d'Ivoire | ZUVENTUS HEALTHCARE | expired | Feb 2024 |
| LODINE TABLETS 300 mg* | 🇿🇦South Africa | AKROMED PRODUCTS (PTY) LTD | suspended | Jan 2024 |
| LODINE TABLETS 200 mg* | 🇿🇦South Africa | AKROMED PRODUCTS (PTY) LTD | suspended | Jan 2024 |
| LODINE CAPSULES 300 mg* | 🇿🇦South Africa | AKROMED PRODUCTS (PTY) LTD | active | Jan 1900 |
| LODINE comprimé / 300 mg | 🇸🇳Senegal | WYETH FRANCE | active | — |
| Proxym-300 Tablet, Film-coated | 🇹🇿Tanzania | Emcure Pharmaceuticals Ltd | active | — |
| Etova - 400 Tablets | 🇹🇿Tanzania | IPCA Laboratories Limited | active | — |
| LODINE comprimé pelliculé / 300mg | 🇸🇳Senegal | DEXO | active | — |
ETODOLAC in Africa — Regulatory Overview
ETODOLAC is registered across 5 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Côte d'Ivoire, Senegal, Tanzania and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 7 (70%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.